智通财经APP获悉，2月21日，恒生指数公司公布最新季检结果，其中讯飞医疗科技(02506)获纳入恒生综合指数成份股，所有变动将于2025年3月7日(星期五)收市后实施并于2025年3月10日(星期一)起生效。据中信证券研报估算，讯飞医疗科技有可能被纳入港股通，因其满足了包括市值、流动性和上市时间等在内的一系列标准。
2月19日，医疗人工智能领军企业讯飞医疗科技与中国第三方医学影像服务领军企业一脉阳光在北京正式签署战略合作协议。本次合作中，双方将依托各自资源优势，围绕优势区域联合市场开发、优势产品与业务模式合作、创新投资模式探索、共建区域医疗可信数据空间、医疗大模型及医学影像AI诊断大模型合作研发、智能化健康管理业务探索等领域展开深度合作，加速优质医疗资源普惠化进程。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.